A multi-biomarker approach for discrimination of angiographically detected coronary artery disease in metabolic dysfunction-associated steatotic liver disease: the utility of routine laboratory indices
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally prevalent chronic liver disease. Accumulating evidence indicates that MASLD is closely linked to coronary artery disease (CAD) through the liver-heart axis, with insulin resistance, chronic systemic inflammation and lipid disorders as...